Fundraising FoxBrightstone Venture Capital — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Celcuity is a commercial-stage biotechnology company developing targeted cancer therapies for tumors involving the PAM (PI3K/AKT/mTOR) pathway, including breast, prostate, lung, endometrial, colon, and ovarian cancers.
BiotechHealthtechMedical DevicesMinneapolis, US
Lance G. Laing(Executive Officer, Director, Promoter)inBrian F. Sullivan(Executive Officer, Director, Promoter)inLance G. Laing, Ph.D.(Chief Science Officer, Vice President, Secretary and Director)Vicky Hahne(Executive Officer)in
BoardDavid F. Dalvey(Director)inRichard E. Buller(Director)
Board seatDavid Dalvey· per SEC Form D
Co-investorsNew Enterprise Associates (NEA)
Afriex provides a remittance service enabling immigrants to transfer money to over 25 countries at low costs with rapid settlement.
FintechSan Francisco, US
Tope Alabi(Founder)inJohn Obirije(Founder)inEugene Baah(Head of Product)
Co-investorsAdaverseDragonflyFoundersFuture AfricaGaingelsMetastable+10 more
__Twitter.png)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.